These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 22935141

  • 1. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
    Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y, Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH, Liu LZ.
    J Mol Cell Biol; 2013 Feb; 5(1):3-13. PubMed ID: 22935141
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR, He Y, Huang C, Li J.
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [Abstract] [Full Text] [Related]

  • 3. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
    Wang X, Liang Z, Xu X, Li J, Zhu Y, Meng S, Li S, Wang S, Xie B, Ji A, Liu B, Zheng X, Xie L.
    Cell Death Dis; 2016 Dec 01; 7(12):e2503. PubMed ID: 27906180
    [Abstract] [Full Text] [Related]

  • 4. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R, Gu J, Jiang P, Zheng Y, Liu X, Jiang X, Huang E, Xiong S, Xu F, Liu G, Ge D, Chu Y.
    Clin Cancer Res; 2015 Feb 15; 21(4):854-63. PubMed ID: 25512445
    [Abstract] [Full Text] [Related]

  • 5. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D, Deb M, Rath SK, Kar S, Parbin S, Pradhan N, Patra SK.
    Exp Cell Res; 2016 Aug 15; 346(2):176-87. PubMed ID: 27475839
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.
    Zhu A, Xia J, Zuo J, Jin S, Zhou H, Yao L, Huang H, Han Z.
    Med Oncol; 2012 Dec 15; 29(4):2701-9. PubMed ID: 22167392
    [Abstract] [Full Text] [Related]

  • 7. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL, Miao ZF, Chen YT, Huang CW, Yeh YS, Yang IP, Wang JY.
    J Cell Mol Med; 2019 May 15; 23(5):3572-3582. PubMed ID: 30834693
    [Abstract] [Full Text] [Related]

  • 8. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
    Liu MM, Li Z, Han XD, Shi JH, Tu DY, Song W, Zhang J, Qiu XL, Ren Y, Zhen LL.
    Sci Rep; 2017 Nov 21; 7(1):15929. PubMed ID: 29162879
    [Abstract] [Full Text] [Related]

  • 9. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
    Zhang Q, Zhou X, Wan M, Zeng X, Luo J, Xu Y, Ji L, Zhang JA, Fan P, Zhong J, Wu J.
    Cell Death Dis; 2021 Mar 15; 12(3):275. PubMed ID: 33723215
    [Abstract] [Full Text] [Related]

  • 10. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T, Ren Y, Wang F, Zhao R, Qiao B, Xing L, Ou L, Guo B.
    Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32202300
    [Abstract] [Full Text] [Related]

  • 11. Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.
    Xu Q, Liu LZ, Yin Y, He J, Li Q, Qian X, You Y, Lu Z, Peiper SC, Shu Y, Jiang BH.
    Oncogene; 2015 Oct 30; 34(43):5482-93. PubMed ID: 25703326
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
    Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH, Liu LZ.
    Biochim Biophys Acta; 2013 Feb 30; 1829(2):239-47. PubMed ID: 23201159
    [Abstract] [Full Text] [Related]

  • 13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y, Li S, Li J, Wang D, Li Q.
    Cell Physiol Biochem; 2017 Feb 30; 42(4):1431-1446. PubMed ID: 28715819
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX, Xu XX, Tan BZ, Zhang Z, Zhou XD.
    Cell Physiol Biochem; 2017 Feb 30; 41(3):933-946. PubMed ID: 28222438
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.
    Wang Y, Zhang X, Zou C, Kung HF, Lin MC, Dress A, Wardle F, Jiang BH, Lai L.
    Biomed Pharmacother; 2016 May 30; 80():95-101. PubMed ID: 27133044
    [Abstract] [Full Text] [Related]

  • 18. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.
    Gao L, Wang X, Wang X, Zhang L, Qiang C, Chang S, Ren W, Li S, Yang Y, Tong D, Chen C, Li Z, Song T, Zhi K, Huang C.
    Oncotarget; 2014 May 15; 5(9):2562-74. PubMed ID: 24810113
    [Abstract] [Full Text] [Related]

  • 19. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
    Wang Y, Hu Y, Guo J, Wang L.
    Genet Test Mol Biomarkers; 2019 Feb 15; 23(2):98-104. PubMed ID: 30735457
    [Abstract] [Full Text] [Related]

  • 20. Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis.
    Liu L, Yi H, Wang C, He H, Li P, Pan H, Sheng N, Ji M, Cai L, Ma Y.
    J Immunol; 2016 Aug 15; 197(4):1231-41. PubMed ID: 27421476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.